ICLR : Analysis & Opinions

  1. Air Methods: A Strong Sell on Weak Q3 & Estimate Revision - Analyst ...

    December 17, 2014
    On Dec 17, 2014, Zacks Investment Research downgraded medical services provider Air Methods Corp (AIRM) to a Zacks Rank #5 ...
  2. ICON (ICLR) Now a Strong Buy: Should It Be in Your Portfolio? ...

    December 16, 2014
    ICON has been witnessing rising earnings estimates on the back of a new FDA project and an increased guidance for fiscal ...
  3. The “Healthy” Play In Contract Research Organizations

    April 17, 2013
    The pharmaceutical industry is under pressure to do more with less. That means it will be farming out many of is mundane ...
  4. The Long-Term Play In Lab Work

    January 16, 2012
    As drugmakers beef up their pipelines in this world of rising costs, the contract research sector should profit.
  5. PPD Goes Private

    October 6, 2011
    PPD's acceptance of a low buyout bid raises questions about the CRO industry.
  6. Irish Stocks Present Possible Value Play

    March 9, 2011
    Despite its fiscal woes, Ireland' tech story could ultimately become its saving grace.
  7. Playing Big Pharma With CROs

    July 6, 2010
    Investors looking to play the growth in R&D spending for human drugs should consider CROs.
Trading Center